Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-10-10
2006-10-10
Zara, Jane (Department: 1635)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C435S006120, C435S091100, C435S455000, C435S458000, C536S023100
Reexamination Certificate
active
07119078
ABSTRACT:
The present invention relates to methods of intracellular delivery of oligonucleotides. More particularly, the present invention relates to the use of the delivery system to deliver G-quartet oligonucleotides as a cancer therapy or an anti-viral therapy.
REFERENCES:
patent: 6040181 (2000-03-01), Reed
patent: 6288042 (2001-09-01), Rando et al.
patent: WO 97/20924 (1997-06-01), None
M. Nielsen et al. Eur. J. Immunol. vol. 24, pp. 3082-3086 (1994).
J. E. Darnell, Jr. Science, vol. 77, pp. 1630-1635 (1997).
R. Tam et al. J. Immunol. vol. 163, No. 8, pp. 200-208 (1997).
A. Peracchi et al. Rev. Med. Virol. vol. 14, pp. 47-64 (2004).
A. Branch, Trends in Biochem. Sci. vol. 23, pp. 45-50 (1998).
C. A. Stoddart et al. Antimicrobial Agents & Chemotherapy, vol. 42, No. 8, pp. 2113-2115 (1998).
P. J. Bates et al. J. Biol. Chem. vol. 274, No. 37, pp. 26,369-26,377 (1999).
P. J. Bates, et al. Proc. Am. Assoc. Cancer Res. Ann. Mtg. vol. 39, p. 64, Abstract No. 436 (1998).
T. Chirila et al. Biomaterials, vol. 23, pp. 321-342 (2002).
S. Crooke, Antisense Res. and Application, Chapter 1, pp. 1-50, S. Crooke, ed. Publi. Springer-Verlag (1998).
N. Jing, Expert Opinion on Investigational Drugs, vol. 9, No. 8, pp. 1777-1785 (2000).
S. Agrawal et al. Molecular Med. Today, vol. 61, pp. 72-81 (2000).
Jing, Naijie, et al.; Rational Drug Design of DNA Oligonucleotides as HIV Inhibitors; Current Drug Targets—Infectious Disorders, 2001, 1, 79-90.
Jing, Naijie, et al.; Potassium-Induced Loop Conformational Transition of a Potent Anti-HIV Oligonucleotide; Journal of Biomolecular Structure & Dynamics, vol. 15 (3), pp. 573-585, 1997.
Jing, Naijie, et al.; Potassium-Dependent Foldling: A Key to Intracellular Delivery of G-Quartet Oligonucleotides as HIV Inhibitors; Biochemistry, vol. 41 (17), pp. 5397-5403, 2002.
Jing, Naijie, et al.; Structure-Activity of Tetrad-forming Oligonucleotides as a Potent Anti-HIV Therapeutic Drug; The Journal of Biological Chemistry, vol. 273 (52), pp. 34992-34999, Dec. 25, 1998.
Wang, Die, et al.; Stearylamine Liposome as a New Efficient Reagent for DNA Transfection of Eukaryotic Cells; Biochemical and Biophysical Research Communications 226, pp. 450-455, 1996.
Jing, Naijie, et al.; Stability-Activity Relationships of a Family of G-tetrad Forming Oligonucleotides as Potent HIV Inhibitors; The Journal of Biological Chemistry; vol. 275 (5), pp. 3421-3430, Feb. 4, 2000.
Jing, Naijie, et al.; Mechanism of Inhibition of HIV-1 Integrase by G-tetrad-forming Oligonucleotides in Vitro; The Journal of Biological Chemistry, vol. 275 (28), pp. 21460-21467, Jul. 14, 2000.
Jing, Naijie, et al.; Ion Selective Folding of Loop Domains in a Potent Anti-HIV Oligonucleotide; Biochemistry, vol. 36 (41), pp. 12498-12505, 1997.
Guan Yongli
Jing Naijie
Xiong Weijun
Baylor College of Medicine
Fulbright & Jaworski L.L.P.
Zara Jane
LandOfFree
Technology of intracellular delivery of DNA oligonucleotides... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Technology of intracellular delivery of DNA oligonucleotides..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Technology of intracellular delivery of DNA oligonucleotides... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3675447